106 Results for "

sEH

" in MedChemExpress (MCE) Product Catalog:
Products (106)

106 Results for "sEH" in MCE Product Catalog:

14
14 Publications Verification
Cat. No.: HY-101294
CAS No.: 1222780-33-7
Purity:  99.10%
Target:  

Epoxide Hydrolase

Research Areas:  

Inflammation/Immunology

TPPU is a soluble epoxide hydrolase (sEH) inhibitor with IC50 values of 37 and 3.7 nM for monkey and human sEH, respectively.
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-108570
CAS No.: 479413-70-2
Purity:  ≥98.0%
Target:  

Epoxide Hydrolase

Research Areas:  

Inflammation/Immunology

AUDA (compound 43) is a potent soluble epoxide hydrolase (sEH) inhibitor with IC50s of 18 and 69 nM for the mouse and human sEH, respectively . AUDA has anti-inflammatory activity .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-113974
CAS No.: 885012-33-9
Purity:  98.16%
Synonyms: t-AUCB
Target:  

Epoxide Hydrolase

Research Areas:  

Cancer

trans-AUCB (t-AUCB) is a potent, orally active and selective soluble epoxide hydrolase (sEH) inhibitor with IC50s of 1.3 nM, 8 nM, 8 nM for hsEH, mouse sEH and rat sEH, respectively. trans-AUCB has anti-glioma activity .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-19644
CAS No.: 1142090-23-0
Synonyms: GSK 2256294
Target:  

Epoxide Hydrolase

Research Areas:  

Cardiovascular Disease

GSK2256294A (GSK 2256294) is a selective and orally active inhibitor of soluble epoxide hydrolase (sEH). GSK2256294A inhibits recombinant human sEH, rat sEH orthologs and murine sEH orthologs with IC50s of 27, 61 and 189 pM, respectively. GSK2256294A can be used for the research of chronic obstructive pulmonary disease (COPD) and cardiovascular disease .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-128171
CAS No.: 724453-98-9
Purity:  99.67%
Target:  

FLAP Epoxide Hydrolase

Research Areas:  

Inflammation/Immunology

Diflapolin is a highly active dual 5-lipoxygenase-activating protein (FLAP)/soluble epoxide hydrolase (sEH) inhibitor with marked anti-inflammatory efficacy and high target selectivity. Diflapolin inhibits 5-LOX product formation in intact human monocytes and neutrophils with IC50s?of? 30 and 170?nM, respectively, and suppressed the activity of isolated sEH (IC50=20?nM) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-135653
CAS No.: 1809885-32-2
Purity:  98.13%
Synonyms: BPN-19186
Target:  

Epoxide Hydrolase

Research Areas:  

Neurological Disease

EC5026 (BPN-19186) is a first-in-class, non-opioid and orally active soluble Epoxide Hydrolase (sEH) inhibitor. EC5026 shows efficacy for inflammatory and neuropathic pain .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-121538
CAS No.: 479413-68-8
Purity:  ≥98.0%
Target:  

Epoxide Hydrolase PPAR

Research Areas:  

Cardiovascular Disease

CUDA is a potent inhibitor of soluble epoxide hydrolase (sEH), with IC50s of 11.1 nM and 112 nM for mouse sEH and human sEH, respectively . CUDA selectively increases peroxisome proliferator-activated receptor (PPAR) alpha activity. CUDA may be valuable for the research of cardiovascular disease .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-124063
CAS No.: 940954-41-6
Purity:  98.01%
Target:  

Epoxide Hydrolase

Research Areas:  

Cardiovascular Disease

BI-1935, a chemical probe, is a potent soluble epoxide hydrolase (sEH) inhibitor. BI-1935 can be used for the research of cardiovascular disease .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-N0805A
CAS No.: 18649-93-9
Alisol B is a triterpene with diverse biological activities. Alisol B binds human soluble epoxide hydrolase (sEH) with a Ki of 5.97 μM and reduces sEH activity. Alisol B inhibits RANKL-induced JNK phosphorylation, NFATc1 and c-Fos expression, osteoclast formation, mature osteoclast pit-forming and actin ring activity, and SERCA pump activity. Alisol B induces calcium mobilization, CaMKK-AMPK-mTOR pathway activation, autophagic flux, autophagosome formation, G1 phase cell cycle arrest, endoplasmic reticulum stress, unfolded protein responses, and cancer cell apoptosis. Alisol B can be used for the research of hypercalcemia, osteoporosis, rheumatoid arthritis, periodontitis, acute kidney injury, and breast cancer .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-122591
CAS No.: 1287761-01-6
Purity:  98.69%
Target:  

COX

Research Areas:  

Metabolic Disease Cancer

PTUPB is a potent and dual sEH and COX-2 enzymes inhibitor with IC50 of 0.9 nM and 1.26 μM, respectively .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-121538A
Target:  

Epoxide Hydrolase PPAR

Research Areas:  

Cardiovascular Disease

CUDA disodium is a potent inhibitor of soluble epoxide hydrolase (sEH), with IC50s of 11.1 nM and 112 nM for mouse sEH and human sEH, respectively . CUDA disodium selectively increases peroxisome proliferator-activated receptor (PPAR) alpha activity. CUDA disodium may be valuable for the research of cardiovascular disease .
loading...
    loading...
Cat. No.: HY-W259932
CAS No.: 2222120-31-0
Target:  

Ligands for E3 Ligase

Research Areas:  

Cancer

Lenalidomide 5'-piperazine (hydrochloride) is a cereblon-recruiting fragment and E3 ligase recruiter in sEH PROTACs .
loading...
    loading...
Cat. No.: HY-111151
CAS No.: 913548-29-5
Purity:  99.69%
Synonyms: APAU
AR9281 (APAU) is a potent, selective and orally active soluble epoxide hydrolase (s-EH) inhibitor. AR-9281 can inhibits human sEH (HsEH) and murine sEH (MsEH) with IC50 values of 13.8 nM and 1.7 nM, respectively. AR9281 can be used for the research of inflammation, hypertension and type 2 diabetes .
loading...
    loading...
Cat. No.: HY-114266
CAS No.: 948304-40-3
Purity:  99.88%
Synonyms: t-TUCB
UC-1728 is a potent rabbit soluble epoxide hydrolase (sEH) inhibitor, with an IC50 of 2 nM on rabbit liver.
loading...
    loading...
Cat. No.: HY-113862
CAS No.: 1028430-42-3
Purity:  ≥99.0%
PHOME is a fluorogenic substrate for sEH. sEH can hydrolyze the epoxy ring in the PHOME substrate. PHOME can be used for fluorescent epoxide hydrolase assay .
loading...
    loading...
Cat. No.: HY-148136
CAS No.: 340221-20-7
Purity:  99.71%
sEH inhibitor-7 is an sEH inhibitor, with an IC50 of 0.15 μM against mouse sEH and an IC50 of 6.2 μM against h-sEH. sEH inhibitor-7 can be used in studies related to hypertension and inflammation .
loading...
    loading...
Cat. No.: HY-126326
CAS No.: 2376322-12-0
Purity:  99.41%
Target:  

Epoxide Hydrolase

Research Areas:  

Metabolic Disease

SWE101 (compound 22 b) is a potent soluble epoxide hydrolase (sEH)-P inhibitor with IC50s of 4 μM and 2.8 μM for human and rat sEH-P, respectively. SWE101 does not inhibit neither hydrolase nor phosphatase activity of the mouse sEH .
loading...
    loading...
Cat. No.: HY-120494
CAS No.: 1208549-68-1
Purity:  99.62%
Target:  

Epoxide Hydrolase

Research Areas:  

Inflammation/Immunology

sEH inhibitor-1 (compound TCPU ) is a potent and oral active inhibitor of sEH (soluble epoxide hydrolase) with IC50s of 0.4 and 5.3 nM in human and murine, respectively .
loading...
    loading...
Cat. No.: HY-W013989
CAS No.: 2387-23-7
Target:  

Epoxide Hydrolase

Research Areas:  

Cardiovascular Disease

1,3-Dicyclohexylurea (DCU) is an orally active and potent sEH (soluble epoxide hydrolase) inhibitor. Oral Delivery of 1,3-Dicyclohexylurea nanosuspension enhances exposure and lowers blood pressure in hypertensive Rats .
loading...
    loading...
Cat. No.: HY-155773
CAS No.: 923509-20-0
Purity:  98.53%
Target:  

FAAH Epoxide Hydrolase

Research Areas:  

Cardiovascular Disease

VU534 is a NAPE-PLD activator, with an EC50 of 0.30 μM. VU534 is dual inhibitors of FAAH and sEH (IC50 of 1.2 μM). VU534 increases efferocytosis in a NAPE-PLD dependent manner. VU534 has the potential for cardiometabolic diseases study [1] .
loading...
    loading...